Repository logo
Repository logo

Repositorio Institucional INC

Repository logo
  • English
  • العربية
  • বাংলা
  • Català
  • Čeština
  • Deutsch
  • Ελληνικά
  • Español
  • Suomi
  • Français
  • Gàidhlig
  • हिंदी
  • Magyar
  • Italiano
  • Қазақ
  • Latviešu
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Српски
  • Svenska
  • Türkçe
  • Yкраї́нська
  • Tiếng Việt
Log In
New user? Click here to register. Have you forgotten your password?
Communities & Collections
All of DSpace
Autoarchivo
  • English
  • العربية
  • বাংলা
  • Català
  • Čeština
  • Deutsch
  • Ελληνικά
  • Español
  • Suomi
  • Français
  • Gàidhlig
  • हिंदी
  • Magyar
  • Italiano
  • Қазақ
  • Latviešu
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Српски
  • Svenska
  • Türkçe
  • Yкраї́нська
  • Tiếng Việt
Log In
New user? Click here to register. Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Santiago Téllez Buitrago Ribero"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Item
    Nefopam, ¿Útil para él dolor neuropático?
    (Revista Chilena de Anestesia, 2024-06-04) Santiago Téllez Buitrago Ribero; Omar Fernando Gomezese; Andrea Gutiérrez
    Nefopam is a drug with very interesting pharmacological characteristics for the treatment of acute postoperative pain, but even more, as an understudied analgesic strategy for neuropathic pain. The present review article was proposed to perform a search with the MeSH terms in (PubMed) with the formula terms (nefopam [MeSH Terms]) AND (neuropathic pain [MeSH Terms]). In this way, a great void of medical literature on a molecule with a great potential for research was evidenced since the sixties in European countries, doctors like Basset and collaborators in 1969 as a potential antidepressant which owes its action in relation to its interaction with the inhibition of monoamine reuptake, suppressive effect on sodium voltage channels and an inhibitory activity on voltage-dependent calcium channels; so, it is a drug with a high likelihood to the antineuropathic ones. At present there are no recommendations or guidelines that support the use of Nefopam for the treatment of neuropathic pain and so it is interesting to make a review article that can examine the little literature found and allow to awaken the interest of clinical researchers to add an intravenous analgesic strategy for neuropathic pain.
Instituto Nacional de Cancerología
  • Sede principal
  • Dirección: Calle 1 # 9 -85 Bogotá DC, Colombia Bogotá DC, Colombia
  • Código postal: 111511-110411001
  • Horario de atención: Lunes a Viernes de 7:00 a.m. a 4:00 p.m. en jornada continua
  • Teléfono conmutador: (57) (601) 4817000
  • Teléfono solicitud citas: (57) (601) 4846050
  • Teléfono resto del país: 01 8000 414414
  • Correo notificaciones judiciales: notificacionesjudiciales@cancer.gov.co
  • Correo electrónico anticorrupción: soytransparente@cancer.gov.co
  • Correo electrónico correspondencia: gestiondocumental@cancer.gov.co
  • Correo electrónico para glosas y devoluciones: glosas@cancer.gov.co
  • Denuncias por posibles actos de corrupción
X
@INCancerologia
Instagram
@incancerologia
Facebook
@INCancerologiaESE
Instituto Nacional de Cancerología
Acreditación Icontec
Certificacion Icontec
Certificacion IQnet
  • SIAI
  • REDCAP
Políticas de tratamiento de datos personales
Políticas de seguridad y privacidad de la información
Términos de uso

Tecnología DSpace implementada por